Intelligence

Flow Cytometry Basics Guide

Flow cytometry is a powerful tool allowing you to detect, measure, and quantify single cells or particles in suspension as they pass through a laser. However, to produce impactful results, experiments must be designed with care. This guide takes you through the fundamentals of flow cytometry, provides useful practical advice… Read More

#Intelligence #Resources

#AI / data analytics / healthtech / informatics #Comment #Healthcare #Public health

Expert perspective: 2022 challenges and opportunities

DDW’s Megan Thomas speaks to decision-makers from the drug discovery industry about their predictions on what 2022 holds for our sector.   Around this time last year, the first Covid-19 vaccines were authorised for emergency use by organisations such as the FDA1, the EMA2, the MHRA3… Read More

#Editor's Choice #Exclusive Content #Intelligence #News #Opinion #Trends & Analysis

#Biotechnology #Clinical trials #Imaging

Industry predictions for clinical trials 

Medidata reflects on how clinical trials have evolved over the past year, as well as emerging patterns and drivers of change for the coming year. Paul O’Donohoe and Fiona Maini from Medidata explain.  1. The future of clinical trials is decentralised  Decentralised clinical trials, described as… Read More

#Editor's Choice #Exclusive Content #Intelligence #News #Opinion #Trends & Analysis

Targeting kinases involved in the innate immune response 

Clinical trials continue to determine whether therapeutic modulation of kinases can be used to suppress the immune system in autoimmune diseases or stimulate for antiviral and cancer immunotherapy. The discovery and characterisation of small molecule modulators have aided these efforts.   The Transcreener ADP² Kinase Assay meets this need as it relies… Read More

#Intelligence #Resources

Radioactivity Assays for Methyltransferases

SAMDI Tech’s radioactivity assays overcome key challenges in drug discovery by offering key solutions, including: Detecting low amounts of product with sensitive assays Generating data rapidly with high-throughput, 384-well capabilities Characterising potent inhibitors by benefiting from lower enzyme concentrations In this free to download TechNote, learn how SAMDI Tech’s… Read More

#Intelligence #Resources

Human eye
#Clinical trials #Comment #Covid-19 #Eye health

Innovative delivery: sustained ophthalmic steroids in diabetic macular edema 

Listen to this article on the DDW Podcast: Professor Sobha Sivaprasad, Professor of Retinal Clinical Studies, UCL Institute of Ophthalmology, and Consultant Ophthalmologist, Moorfields Eye Hospital, UK discusses unmet needs in DME therapeutics and how they could be addressed by sustained release ophthalmic steroids administered with novel suprachoroidal drug… Read More

#Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis

#AstraZeneca #Biobanking #Genetics #Genomics

Rare variant contribution to human disease  

Listen to this article on the DDW Podcast: Slavé Petrovski and Andrew Harper, Centre for Genomics Research, AstraZeneca, outline the implications and insight offered by the recent publication of an AstraZeneca-authored paper “Rare variant contribution to human disease in 281,104 UK Biobank exomes”.  In August 2021, Nature published… Read More

#Exclusive Content #News #Opinion #Trends & Analysis

Antibody Production

In immunoassays-based research, immunodiagnostics, as well as immunotherapy, one of the highly critical aspect of antibodies is their reproducible performance. Antibody reproducibility is driven by their specificity and several other factors ranging from antibody design to target validation. This NEW eBook Antibody Production gives you an overview of the antibody’s life cycle… Read More

#Intelligence #Resources

#Comment #Covid-19 #Genetics #Genomics #Public health #Research

Genomics boosts understanding of Covid-19 severity and susceptibility

Listen to this article on the DDW Podcast: The Covid-19 Host Genetics Initiative carried out one of the largest genome-wide association studies ever. It involved meta-analysis of nearly 50,000 Covid-19 patients and two million uninfected controls. Dr Hamdi Mbarek, Lead Analyst of the Qatari dataset explains how the initiative… Read More

#Covid-19 #Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis

#Drug discovery #Drug targets #Drug technology #Pharmaceuticals #Quantum computing

How quantum computing can benefit drug discovery 

Listen to this article on the DDW Podcast: Brad Loren, Matthew Marrone, and Christopher Singer, of intellectual property and technology law firm McAndrews, Held & Malloy, on quantum computing and its benefits to drug discovery.  Explaining quantum computing and its promise  Before we… Read More

#Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis

Bridging the throughput gap: Process optimisation in antibody discovery workflows

Discover how process optimisation utilising automated synthetic biology solutions can remove the antibody sequence cloning bottleneck that divides high-content lead identification and downstream high throughput characterisation. If your work involves antibody discovery or process improvement in recombinant cloning don’t miss this whitepaper illustrating how Codex DNA’s synthetic biology solutions can… Read More

#Intelligence #Resources

Download our App

Drug Discovery World is the global voice for the drug discovery community. From research stage to clinical trials the brand covers the scientific and commercial process involved in getting a drug to market – research, target identification and validation, drug molecule identification, lead molecule optimisation, pre-clinical research, clinical… Read More

#Archive

#Clinical trials #Drug development

Data suggests racial diversity underrepresented in clinical trials 

Phesi has analysed protocol design data and showed that Asian, Hispanic and Latino, Native Americans and Alaska natives, Native Hawaiians and other Pacific Islander patient subpopulations were all significantly and consistently underrepresented over the decade. Black and African American patients appear to have become better represented over the past decade.  The… Read More

#News #Trending News #Trends & Analysis

#Biopharma #Biotechnology #Drug innovation #Pharmaceuticals #Report #Research

Pharmaceuticals and biotech lead UK university innovation 

University technology and innovation is driving the UK’s status in pharmaceuticals and biotechnology, according to GovGrant’s University Spinouts Report 2021.  The report  According to the new report, the pharmaceuticals and biotechnology sector dominates the top ten spinout companies of the last decade, ranked by valuation. Pharma and… Read More

#News #Trends & Analysis